Renal dysfunction in burns: A review

Annals of Burns and Fire Disasters

Volumn 26, Issue 1, 2013, Pages 16-25

  Ibrahim, Amir E ^a   Sarhane, K A ^b   Fagan, S P ^a   Goverman, J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Classification of kidney injury; Dialysis in burns; Kidney dysfunction in burns; Renal failure in burns; Treatment of renal failure

Indexed keywords

EID: 84879488318     PISSN: 11211539     EISSN: 15929566     Source Type: Journal    
DOI: None     Document Type: Review

References (121)

1. Uchino S: The epidemiology of acute renal failure in the world. Current opinion in critical care, 12: 538-43, 2006.
2. Chertow GM, Christiansen CL, Cleary PD et al.: Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Archives Internal Medicine, 155: 1505-11, 1995.
3. Liano F, Junco E, Pascual J et al.: The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. Kidney International Supplement, 66: S16-24, 1998.
4. Star RA: Treatment of acute renal failure. Kidney International, 54: 1817-31, 1998.
5. Belba M, Belba G: Acute renal failure in severe burns: Conclusion after analysis of deaths during 1998. Ann Burns Fire Disasters, 13: 77-80, 2000.
6. Chertow GM, Burdick E, Honour M et al.: Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J American Society Nephrology, 16: 3365-70, 2005.
7. Coca SG, Yusuf B, Shlipak MG et al.: Long-term risk of mortality and other adverse outcomes after acute kidney injury: A systematic review and meta-analysis. American J Kidney Diseases, 53: 961-73, 2009.
8. Kim G-H, Oh KH, Yoon JW et al.: Impact of burn size and initial serum albumin level on acute renal failure occurring in major burn. American J Nephrology, 23: 55-60, 2003.
9. Curiel-Balsera E, Prieto-Palomino MA, Fernandez-Jimenez S et al.: Epidemiology, initial management and analysis of morbidity/ mortality of severe burn patient. Medicina intensiva / Sociedad Espanola de Medicina Intensiva y Unidades Coronarias, 30: 363-9, 2006.
10. Lopes JA, Jorge S, Neves FC et al.: An assessment of the RIFLE criteria for acute renal failure in severely burned patients. Nephrology, dialysis, transplantation. Official Publication of the European Dialysis and Transplant Association-European Renal Association, 22: 285, 2007.
11. Palmieri T, Lavrentieva A, Greenhalgh DG: Acute kidney injury in critically ill burn patients. Risk factors, progression and impact on mortality. Burns, 36: 205-11, 2010.
12. Palevsky PM: Renal replacement therapy in acute kidney injury. Advances in Chronic Kidney Disease, 20: 76-84, 2013.
13. Bellomo R, Ronco C, Kellum JA et al.: Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs. Second International Consensus Conference of the Acute Dialysis Quality Initiative Group. Critical Care (London, England), 8: R204-12, 2004.
14. Brochard L, Abroug F, Brenner M et al.: An official ATS/ERS/ESICM/ SCCM/SRLF statement: Prevention and management of acute renal failure in the ICU patient. International Consensus Conference in Intensive Care Medicine. American J Respiratory and Critical Care Medicine, 181: 1128-55, 2010.
15. Bagshaw SM, George C, Bellomo R: A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrology, dialysis, transplantation: Official Publication of the European Dialysis and Transplant Association-European Renal Association, 23: 1569-74, 2008.
16. Mosier MJ, Pham TN, Klein MB et al.: Early acute kidney injury predicts progressive renal dysfunction and higher mortality in severely burned adults. J Burn Care Research, 31: 83-92, 2010.
17. Davies DM, Pusey CD, Rainford DJ et al.: Acute renal failure in burns. Scandinavian J Plastic and Reconstructive Surgery, 13: 189-92, 1979.
18. Planas M, Wachtel T, Frank H et al.: Characterization of acute renal failure in the burned patient. Archives Internal Medicine, 142: 2087-91, 1982.
19. Schiavon M, Di Landro D, Baldo M et al.: A study of renal damage in seriously burned patients. Burns, 14: 107-12, 1988.
20. Haberal M, Ozdemir A, Bayraktar U et al.: Gastrointestinal and renal complications in burned patients. Ann Burns Fire Disasters, 6: 26-28, 1993.
21. Borgognone A, Gherardini G: Disseminated intravascular coagulation as the underlying cause of multiple organ failure in burned patients: Preliminary observations. Ann Burns Fire Disasters, 4: 13-15, 1991.
22. Bouchard J, Soroko SB, Chertow GM et al.: Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney International, 76: 422-7, 2009.
23. Heung M, Wolfgram DF, Kommareddi M et al.: Fluid overload at initiation of renal replacement therapy is associated with lack of renal recovery in patients with acute kidney injury. Nephrology, dialysis, transplantation: Official Publication of the European Dialysis and Transplant Association-European Renal Association, 27: 956-61, 2012.
24. Payen D, De Pont AC, Sakr Y et al.: A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Critical Care (London, England), 12: R74, 2008.
25. Cartotto R, Choi J, Gomez M et al.: A prospective study on the implications of a base deficit during fluid resuscitation. J Burn Care Rehabil, 24: 75-84, 2003.
26. Cochran A, Edelman LS, Saffle JR et al.: The relationship of serum lactate and base deficit in burn patients to mortality. J Burn Care & Research, 28: 231-40, 2007.
27. Jeng JC, Lee K, Jablonski K et al.: Serum lactate and base deficit suggest inadequate resuscitation of patients with burn injuries: Application of a point-of-care laboratory instrument. J Burn Care Rehabil, 18: 402-5, 1997.
28. Kaups KL, Davis JW, Dominic WJ: Base deficit as an indicator or resuscitation needs in patients with burn injuries. J Burn Care Rehabil, 19: 346-8, 1998.
29. Wolf SE, Rose JK, Desai MH et al.: Mortality determinants in massive pediatric burns. An analysis of 103 children with > or = 80% TBSA burns > or = 70% full-thickness). Annals Surgery, 225: 554-69, 1997.
30. Davis JW: The relationship of base deficit to lactate in porcine hemorrhagic shock and resuscitation. J Trauma, 36: 168-72, 1994.
31. Braquet M, Carsin H, Guilbaud J et al.: Plasma atrial natriuretic peptide in severe thermal injury. Lancet, 2: 456, 1986.
32. Nguyen NL, Gun RT, Sparnon AL et al.: The importance of initial management: A case series of childhood burns in Vietnam. Burns, 28: 167-72, 2002.
33. Jeschke MG, Barrow RE, Wolf SE et al.: Mortality in burned children with acute renal failure. Arch Surg (Chicago, Ill: 1960), 133: 752-6, 1998.
34. Ioannovich J, Alexakis D, Parker J et al.: Parkland formula as a guide for resuscitation. Ann Burns Fire Disasters, 2: 29-33, 1989.
35. Davis JW, Shackford SR, Mackersie RC et al.: Base deficit as a guide to volume resuscitation. J Trauma, 28: 1464-7, 1988.
36. Navar PD, Saffle JR, Warden GD: Effect of inhalation injury on fluid resuscitation requirements after thermal injury. American J Surgery, 150: 716-20, 1985.
37. Klein MB, Silver G, Gamelli RL et al.: Inflammation and the host response to injury: An overview of the multicenter study of the genomic and proteomic response to burn injury. J Burn Care & Research, 27: 448-51, 2006.
38. Finnerty CC, Jeschke MG, Herndon DN et al.: Temporal cytokine profiles in severely burned patients: A comparison of adults and children. Molecular Medicine (Cambridge, Mass), 14: 553-60, 2008.
39. Saffle JIL: The phenomenon of "fluid creep" in acute burn resuscitation. J Burn Care & Research, 28: 382-95, 2007.
40. Cancio LC, Chavez S, Alvarado-Ortega M et al.: Predicting increased fluid requirements during the resuscitation of thermally injured patients. J Trauma, 56: 404-14, 2004.
41. Klein MB, Hayden D, Elson C et al.: The association between fluid administration and outcome following major burn: A multicenter study. Ann Surgery, 245: 622-8, 2007.
42. Hobson KG, Young KM, Ciraulo A et al.: Release of abdominal compartment syndrome improves survival in patients with burn injury. J Trauma, 53: 1129-34, 2002.
43. Harman PK, Kron IL, McLachlan HD et al.: Elevated intra-abdominal pressure and renal function. Ann Surgery, 196: 594-7, 1982.
44. Kashtan J, Green JF, Parsons EQ et al.: Hemodynamic effect of increased abdominal pressure. J Surgical Research, 30: 249-55, 1981.
45. Richardson JD, Trinkle JK: Hemodynamic and respiratory alterations with increased intra-abdominal pressure. J Surgical Research, 20: 401-4, 1976.
46. Malbrain MLNG, Chiumello D, Pelosi P et al.: Incidence and prognosis of intra-abdominal hypertension in a mixed population of critically ill patients: A multiple-center epidemiological study. Critical Care Medicine, 33: 315-22, 2005.
47. Greenhalgh DG, Warden GD: The importance of intra-abdominal pressure measurements in burned children. J Trauma, 36: 685-90, 1994.
48. Ivy ME, Atweh NA, Palmer J et al.: Intra-abdominal hypertension and abdominal compartment syndrome in burn patients. J Trauma, 49: 387-91, 2000.
49. O'Mara MS, Slater H, Goldfarb IW et al.: A prospective, randomized evaluation of intra-abdominal pressures with crystalloid and colloid resuscitation in burn patients. J Trauma, 58: 1011-8, 2005.
50. Elgjo GI, Poli de Figueiredo LF, Schenarts PJ et al.: Hypertonic saline dextran produces early (8-12 hrs) fluid sparing in burn resuscitation: A 24-hr prospective, double-blind study in sheep. Critical Care Medicine, 28: 163-71, 2000.
51. Griswold JA, Anglin BL, Love RT et al.: Hypertonic saline resuscitation: Efficacy in a community-based burn unit. Southern Medical Journal, 84: 692-6, 1991.
52. Guha SC, Kinsky MP, Button B et al.: Burn resuscitation: Crystalloid versus colloid versus hypertonic saline hyperoncotic colloid in sheep. Critical Care Medicine, 24: 1849-57, 1996.
53. Kramer GC, Gunther RA, Nerlich ML et al.: Effect of dextran-70 on increased microvascular fluid and protein flux after thermal injury. Circulatory Shock, 9: 529-41, 1982.
54. Milner SM, Kinsky MP, Guha SC et al.: A comparison of two different 2400 mOsm solutions for resuscitation of major burns. J Burn Care Rehabil, 18: 109-15, 1997.
55. Arlati S, Storti E, Pradella V et al.: Decreased fluid volume to reduce organ damage: A new approach to burn shock resuscitation? A preliminary study. Resuscitation, 72: 371-8, 2007.
56. Abu-Sittah GS, Sarhane KA, Dibo SA et al.: Cardiovascular dysfunction in burns: Review of the literature. Ann Burns Fire Disasters, 25: 26-37, 2012.
57. Jeschke MG, Chinkes DL, Finnerty CC et al.: Pathophysiologic response to severe burn injury. Ann Surgery, 248: 387-401, 2008.
58. Blalock A: Experimental shock. VIII. The importance of the local loss of fluid in the production of the low blood pressure after burns. Arch Surg, 22: 610-7, 1931.
59. Becker RA, Vaughan GM, Goodwin CW et al.: Plasma norepinephrine, epinephrine, and thyroid hormone interactions in severely burned patients. Arch Surg (Chicago, Ill: 1960), 115: 439-43, 1980.
60. Crum R, Bobrow B, Shackford S et al.: The neurohumoral response to burn injury in patients resuscitated with hypertonic saline. J Trauma, 28: 1181-7, 1988.
61. Dolecek R, Adamkova M, Sotornikova T et al.: Endocrine response after burn. Scandinavian J Plast Reconstr Surgery, 13: 9-16, 1979.
62. Kelly RA, Smith TW: Cytokines and cardiac contractile function. Circulation, 95: 778-81, 1997.
63. Nora R, Abrams JS, Tait NS et al.: Myocardial toxic effects during recombinant interleukin-2 therapy. J National Cancer Institute, 81: 59-63, 1989.
64. Baxter CR: Fluid volume and electrolyte changes of the early postburn period. Clinics in Plastic Surgery, 1: 693-703, 1974.
65. 2consumption during hemorrhage. Archives Internationales Pharmacodynamie et Therapie, 204: 228-41, 1973.
66. Cioffi WG, DeMeules JE, Gamelli RL: The effects of burn injury and fluid resuscitation on cardiac function in vitro. J Trauma, 26: 638-42, 1986.
67. Gilmore JP: Cardiovascular changes of the burned dog following the infusion of intravenous solutions. American J Physiology, 190: 513-6, 1957.
68. Munster AM, Di Vincenti FC, Foley FD et al.: Cardiac infections in burns. American J Surgery, 122: 524-7, 1971.
69. Lazarus D, Hudson DA: Fatal rhabdomyolysis in a flame burn patient. Burns, 23: 446-50, 1997.
70. Sharp LS, Rozycki GS, Feliciano DV: Rhabdomyolysis and secondary renal failure in critically ill surgical patients. American J Surgery, 188: 801-6, 2004.
71. Rosen CL, Adler JN, Rabban JT et al.: Early predictors of myoglobinuria and acute renal failure following electrical injury. J Emergency Medicine, 17: 783-9, 1999.
72. Steinvall I, Bak Z, Sjoberg F: Acute kidney injury is common, parallels organ dysfunction or failure, and carries appreciable mortality in patients with major burns: A prospective exploratory cohort study. Critical Care (London, England), 12: R124, 2008.
73. Coca SG, Bauling P, Schifftner T et al.: Contribution of acute kidney injury toward morbidity and mortality in burns: A contemporary analysis. American J Kidney Diseases, 49: 517-23, 2007.
74. Rangel-Frausto MS, Pittet D, Costigan M et al.: The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA, 273: 117-23, 1995.
75. Riedemann NC, Guo R-F, Ward PA: The enigma of sepsis. J Clinical Investigation, 112: 460-7, 2003.
76. Hohlfeld T, Klemm P, Thiemermann C et al.: The contribution of tumour necrosis factor-alpha and endothelin-1 to the increase of coronary resistance in hearts from rats treated with endotoxin. British J Pharmacology, 116: 3309-15, 1995.
77. Schrier RW, Wang W: Acute renal failure and sepsis. New England J Medicine, 351: 159-69, 2004.
78. Czermak BJ, Sarma V, Pierson CL et al.: Protective effects of C5a blockade in sepsis. Nature Medicine, 5: 788-92, 1999.
79. Huber-Lang MS, Riedeman NC, Sarma JV et al.: Protection of innate immunity by C5aR antagonist in septic mice. Federation American Societies Experimental Biology, 16: 1567-74, 2002.
80. Riedemann NC, Guo R-F, Neff TA et al.: Increased C5a receptor expression in sepsis. J Clinical Investigation, 110: 101-8, 2002.
81. Reinhart K, Bayer O, Brunkhorst F et al.: Markers of endothelial damage in organ dysfunction and sepsis. Critical Care Medicine, 30: S302-12, 2002.
82. Lameire N, Hoste E: Reflections on the definition, classification, and diagnostic evaluation of acute renal failure. Current Opinion in Critical Care, 10: 468-75, 2004.
83. Miller PD, Krebs RA, Neal BJ et al.: Polyuric prerenal failure. Archives Internal Medicine, 140: 907-9, 1980.
84. Anderson RJ, Barry DW: Clinical and laboratory diagnosis of acute renal failure. Best Practice & Research Clinical Anaesthesiology, 18: 1-20, 2004.
85. Steiner RW: Interpreting the fractional excretion of sodium. American J Medicine, 77: 699-702, 1984.
86. Zarich S, Fang LS, Diamond JR: Fractional excretion of sodium. Exceptions to its diagnostic value. Archives Internal Medicine, 145: 108-12, 1985.
87. Carvounis CP, Nisar S, Guro-Razuman S: Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney International, 62: 2223-9, 2002.
88. Han WK, Bonventre JV: Biologic markers for the early detection of acute kidney injury. Current Opinion in Critical Care, 10: 476-82, 2004.
89. Levey AS, Stevens LA, Schmid CH et al.: A new equation to estimate glomerular filtration rate. Ann Internal Medicine, 150: 604-12, 2009.
90. Doolan PD, Alpen EL, Theil GB: A clinical appraisal of the plasma concentration and endogenous clearance of creatinine. American J Medicine, 32: 65-79, 1962.
91. Clark WR, Mueller BA, Kraus MA et al.: Quantification of creatinine kinetic parameters in patients with acute renal failure. Kidney International, 54: 554-60, 1998.
92. Moran SM, Myers BD: Course of acute renal failure studied by a model of creatinine kinetics. Kidney International, 27: 928-37, 1985.
93. Stevens LA, Coresh J, Schmid CH et al.: Estimating GFR using serum cystatin C alone and in combination with serum creatinine: A pooled analysis of 3,418 individuals with CKD. American J Kidney Diseases, 51: 395-406, 2008.
94. O'Hare AM, Newman AB, Katz R et al.: Cystatin C and incident peripheral arterial disease events in the elderly: Results from the Cardiovascular Health Study. Archives Internal Medicine, 165: 2666-70, 2005.
95. Peralta CA, Shlipak MG, Fan D et al.: Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. J American Society Nephrology, 17: 2892-9, 2006.
96. Sarnak MJ, Katz R, Stehman-Breen CO et al.: Cystatin C concentration as a risk factor for heart failure in older adults. Ann Internal Medicine, 142: 497-505, 2005.
97. Seliger SL, Longstreth WT, Katz R et al.: Cystatin C and subclinical brain infarction. J American Society Nephrology, 16: 3721-7, 2005.
98. Shlipak MG, Fried LF, Cushman M et al.: Cardiovascular mortality risk in chronic kidney disease: Comparison of traditional and novel risk factors. J American Medical Association, 293: 1737-45, 2005.
99. Shlipak MG, Katz R, Fried LF et al.: Cystatin-C and mortality in elderly persons with heart failure. J American College Cardiology, 45: 268-71, 2005.
100. Shlipak MG, Sarnak MJ, Katz R et al.: Cystatin C and the risk of death and cardiovascular events among elderly persons. New England J Medicine, 352: 2049-60, 2005.
101. Shlipak MG, Wassel-Fyr CL, Chertow GM et al.: Cystatin C and mortality risk in the elderly: The health, aging, and body composition study. J American Society Nephrology, 17: 254-61, 2006.
102. Kellum JA, Levin N, Bouman C et al.: Developing a consensus classification system for acute renal failure. Current Opinion in Critical Care, 8: 509-14, 2002.
103. Rivers E, Nguyen B, Havstad S et al.: Early goal-directed therapy in the treatment of severe sepsis and septic shock. New England J Medicine, 345: 1368-77, 2001.
104. Poeze M, Solberg BCJ, Greve JWM et al.: Monitoring global volume-related hemodynamic or regional variables after initial resuscitation: What is a better predictor of outcome in critically ill septic patients? Critical Care Medicine, 33: 2494-500, 2005.
105. Schiller WR, Bay RC, Mclachlan JG et al.: Survival in major burn injuries is predicted by early response. J Surgery, 170: 696-700, 1995.
106. Ehrie M, Morgan AP, Moore FD et al.: Endocarditis with the indwelling balloon-tipped pulmonary artery catheter in burn patients. J Trauma, 18: 664-6, 1978.
107. Manni C: Prevention and therapy of acute renal failure in severely burned patients. Ann Burns Fire Disasters, 1: 103-6, 1988.
108. Dellinger RP, Carlet JM, Masur H et al.: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Critical Care Medicine, 32: 858-73, 2004.
109. Leblanc M, Thibeault Y, Querin S: Continuous haemofiltration and haemodiafiltration for acute renal failure in severely burned patients. Burns, 23: 160-5, 1997.
110. Cameron JS, Miller-Jones CM: Renal function and renal failure in badly burned children. British J Surgery, 54: 132-41, 1967.
111. Brusselaers N, Monstrey S, Colpaert K et al.: Outcome of acute kidney injury in severe burns: A systematic review and meta-analysis. Intensive Care Medicine, 36: 915-25, 2010.
112. Chung KK, Juncos LA, Wolf SE et al.: Continuous renal replacement therapy improves survival in severely burned military casualties with acute kidney injury. J Trauma, 64: S179-87, 2008.
113. Chung KK, Lundy JB, Matson JR et al.: Continuous venovenous hemofiltration in severely burned patients with acute kidney injury: A cohort study. Critical Care (London, England), 13: R62, 2009.
114. Pomeranz A, Reichenberg Y, Schurr D et al.: Acute renal failure in a burn patient: The advantages of continuous peritoneal dialysis. Burns, 11: 367-70 1985.
115. Bagshaw SM, Berthiaume LR, Delaney A et al.: Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: A meta-analysis. Critical Care Medicine, 36: 610-7, 2008.
116. Vincent JL, Tielemans C: Continuous hemofiltration in severe sepsis: Is it beneficial? J Critical Care, 10: 27-32, 1995.
117. Sieberth HG, Kierdorf HP: Is cytokine removal by continuous hemofiltration feasible? Kidney International Supplement, S79-83, 1999.
118. Faulhaber-Walter R, Hafer C, Jahr N et al.: The Hannover Dialysis Outcome study: Comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit. Nephrology, Dialysis, Transplantation, 24: 2179-86, 2009.
119. Tolwani AJ, Campbell RC, Stofan BS et al.: Standard versus high-dose CVVHDF for ICU-related acute renal failure. J American Society Nephrology, 19: 1233-8, 2008.
120. Bellomo R, Cass A, Cole L et al.: Intensity of continuous renal replacement therapy in critically ill patients. New England J Medicine, 361: 1627-38, 2009.
121. Abichandani R, Pereira BJ: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial, by Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, and La Greca G. Lancet, 355: 26-30, 2000. Seminars in dialysis, 14: 233-4, 2001.